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GENERAL COMMENTS
The critical period for most major congenital anomalies is during organogenesis, in the first trimester of pregnancy. 1. I would like to see more information on the numbers exposed specifically during this period (not just the B3P3 period) in Table 1 : could we have the % with UTI or STI among cases and controls for P1P3 as well as B3P3. 2. Table 2 and Figure 1 : Do these patterns still hold when restricted to P1P3? 3. More discussion of the results relating to this period of exposure would also be useful for e.g. in Figure 2 the aORs for both P1P3 STI and UTI are significant among all ages and those ≥25. This is interesting given the relationship between young maternal age and gastroschisis.
Given the inclusion of exposures in B3B1, are there any references to elaborate on or to support this theory on page 15? "How a GUI might cause gastroschisis during pregnancy remains an open question. In principle, the mechanism could be related to the specific pathogens or alternatively to the inflammatory response generated by the pathogen that may result in cell destruction at the attachment site of the umbilical cord and umbilical ring. If inflammation is the true risk factor and an STI or UTI occurs immediately prior to pregnancy or at the time of conception this may explain the elevated risk we observed in the three month period prior to conception (B3-B1 in fig 2) . Asymptomatic infections can cause inflammation, unbeknownst to the individual, but how long the inflammatory process can continue is not known."
Limitations Interview up to 2 years following the EDD should be acknowledged. Women may not have recalled their infection (helping to explain the lower rates of GUI seen than expected) or may have recalled the timing of infection inaccurately. Similarly, there may be underestimation of STI in particular if women were reluctant to admit they had an STI to the interviewer. There may also have been an element of recall bias with the mother of an infant with gastroschisis more likely to recall an exposure than the mother of a non-malformed infant leading to an overestimation of exposure among malformed infants. I would therefore question the statement that 'risk estimates should represent a lower boundary of the true risk' (page 17).
Consider referencing: Given, J. E., Loane, M., Garne, E. et al. (2017) 'Gastroschisis in Europe -A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk Factors', Paediatric and Perinatal Epidemiology, 31(6), pp. 549-559. doi: 10.1111/ppe.12401 which also found associations between sexually transmitted infections, topical antivirals (used in the treatment of STIs), and oral contraceptives and gastroschisis (of relevance to the discussion relating to cervical ectropion).
This retrospective case control study investigates an important and puzzling phenomenon of a rising rate of gastroschisis in many parts of the world. It is an extension and further exploration of previously published research by the authors utilising the valuable data from the American National Birth Defects Prevention Study cohort. The authors have postulated previously that there is an association with genitourinary infections and gastroschisis in the 3 months prior to conception to the 3 months after conception. This study has extended the study period to end in 2011 (previously 2002) and from the same data questionnaire delineated the time of infection into two time periods. This is important research that may encourage ongoing investigation as the authors state with 'more robust detection methods' for UTI/STI in the time periods under investigation.
This is a well written manuscript on an important topic. A great strength of the research is the interesting data on a large group of gastroschisis cases.
Issues to improve the manuscript: Abstract: Strengths and limitations of this study:
The only limitation the authors state is the issue of the potential misclassification of asymptomatic women as unexposed which would impact both control and cases equally. However, the authors should be more forthcoming in regard to more significant limitations both in this section and within the main body of the manuscript. A significant limitation that should be included is the retrospective nature of the data, collected up to 2 years post event. Also, the potential recall bias between the two groups of cases and control, they potentially recall events of early pregnancy quite differently. Women who have a pregnancy affected by a significant fetal anomaly may well examine carefully all their activities and medical conditions that may have potentially contributed to the pregnancy complication as opposed to women with an unaffected pregnancy. The recall up to two years after the birth would potentially be different. This should be stated as a limitation of the study design.
Material and methods Case classification
For clarity the authors should state the median time from birth to interview for the case group and also the controls with range included.
Statistical analysis Analysis and conclusion in regards to associations within subgroups may be driven by sample size, further review is recommended by Journal statistician.
Conclusion-For clarity to the reader the authors should report n values. For example page 13 line 9 the authors state the strongest association for STI prior to conception was with women < 20 years, reporting the number of women the association is made from would be more transparent. On page 14 line 21 the authors again only report percentages for known STI organisms which is misleading to the reader "(50% of case mother and 36% of control mothers)", please include number of women. 
GENERAL COMMENTS
General This paper reports on the results of a case-control study to examine whether genitourinary infections are a risk factor for gastroschisis in a population-based sample of pregnant women in the US. The paper extends on a previous analysis of the same topic (previously published in the BMJ in 2008), with additional subjects and more detailed exposure data to those in the original study. It is a well-structured paper on an important topic which merits publication, although I have identified some issues that require further clarification.
Methods "Patient and public involvement" on page 6: This section explains how the study subjects were defined and recruited, rather than the role of patients or lay members of the study team in planning and designing the study (as the term PPI would be understood in the UK).
Timing of interviews on page 6: The interviews in this study were conducted up to 2 years after the EDD. As recall bias is likely to be an important potential source of bias in this study, it would be helpful to present summary information on the timing of the interviews and specifically whether this was different between cases and controls (a table could be added to the web appendix and summarised in the methods section).
Exclusion on page 7: Were mothers with pregestational diabetes excluded because gestational diabetes was to be examined as a possible risk factor in the analysis?
Flow of participants on page 7: From the numbers given on page 7, it's not clear how the "participation rates" are 65% and 64% (e.g. given that 1366 of 1506 cases were included in the study group, and the interviews had happened previously as part of the NBDPS). In the STROBE statement, the authors offer to provide a flow diagram of study participants. This would be helpful to clarify what is meant by the "participation rates".
Exposure assessment on page 7:
It is stated that women who said that they had PID were considered to have an STI. However, it is not clear from the description of the questions above this statement that the question on UTIs and PID were separate questions (both questions are included under question a)). Therefore, it is not clear how it's possible to separate women who had UTIs from women who had PID. If these were two separate questions, this should be clarified. Otherwise, it should be clear how the distinction between UTI and PID was made from these questions.
Variables in the model on page 8: A set of covariates for adjustment that were specified a priori is given. This list includes some measures of socio-economic status (such as age and race) but not others (such as education, occupation and/or a measure of wealth). A justification for this is not given (see comment below on the possibility of residual confounding)
No sample size or power calculations are given. This is important in the interpretation of the results, because all of the associations shown in supplementary table 1 are significant in women aged >=25 but this is also the largest group. It is not clear that the study is large enough to show a difference when the data are stratified by infection type, timing and age of the mother.
Results
The statistics used in the paper seem appropriate. However, I'm not familiar with the use of RERIs and whether their use precludes the need for formal tests of interaction. I also wondered whether table 2 would be better shown using a similar figure (with estimates and 95% CIs), so that the reader can see clearly which CIs overlap and which do not? To make way for this, Figure 1 could be taken out as this can easily be summarised in words.
Discussion
The authors discuss the limitations of using maternal recall of infections in general. However, there is potential for differential recall bias in this study, as mothers of babies with gastroschisis may recall and report their exposure to infections in a different way to mothers of babies without gastroschisis. This becomes more likely as the time after the delivery increases (which is why it's important for data on this to be presented). Is it also possible that mothers of babies with gastroschisis may be more likely to notice symptoms or to be investigated for STIs, therefore also introducing a differential information bias (as they may be more likely than control mothers to know their infection status)? This should be explicitly mentioned in the discussion with a statement on how this might affect the interpretation of the ORs.
There is also potential for residual confounding, especially if not all variables relating to the socio-economic status of the mothers were included in the multivariable models (and cases and controls are shown to differ in terms of education). Again, this should be explicitly mentioned in the discussion with a statement on how this might affect the interpretation of the ORs.
The authors explain clearly that the prevalence of gastroschisis is higher in young mothers and that the reasons for this are not well understood (therefore justifying the examination of risk factors that may be more prevalent in young mothers). However, they do not give much detail on the biological plausibility of the association between GUI and gastroschisis (for example, no references are included in the paragraph on page 15 where this is discussed).
Minor comments
Page 3 -the sentence in the results section of the abstract which starts "The risk was also increased with UTI before…" is long and difficult to understand.
Page 11 -the highest "risk" should read "odds"
Page 17 -"these risk estimates…" should read "these estimates"
VERSION 1 -AUTHOR RESPONSE Reviewer: 1 1. Please report the mean/median time to interview between EDD and maternal interviews for case and control mothers.
We have added this information to the Methods section:
The median time to interview was 9.5 (+/-6.3) months for case women and 8.6 (+/-6.5) months for control women.
As an explanation for the reviewer, this slight difference is due to the need for the surveillance system to first identify a potential case with an eligible birth defect, confirm its eligibility, and have the local geneticist review the case prior to inviting the mother to participate in the study. We chose to present the median time since the time to interview distributions are not normally distributed. Also, we are encouraged by the fact that 99.63% of cases and 99.56% of controls finished their interview within the 24 months from EDD. Five cases and 49 controls finished their interview after 24 months from the EDD -there was no difference when compared.
What was the reason for not examining isolated and multiple cases of gastroschisis separately?
Isolated cases represent 91.1% of the gastroschisis cases included in this study. Those that were classified as multiple (n=122, 8.9%) would be a very small group. We would not have had any power to identify differences with such a small sample of multiple cases.
3. Gastroschisis occurs early during pregnancy (4th-8th week of gestation). This information can be presented in the Introduction, and will serve as a rationale for studying periconceptional period.
We have added the following sentence to the Introduction's first paragraph:
If this is the mechanism that results in gastroschisis, the critical timing of an exposure may involve several months: before or after conception or before, during, or, after the merging of the body stalk and omphalomesenteric stalk (21-35 days post-conception) (Feldkamp et al., 2007) .
4.
Alcohol use has been reported as a risk factor for gastroschisis in previous studies. Why was alcohol use not examined as a co-variable? If there was a high correlation between smoking and alcohol, authors can state that in the manuscript. If there was no significant correlation, it would be useful to see results stratified by materinal perinconceptional alcohol use (just as it was presented by smoking status in Table 2 ).
For the initial study on this topic (Feldkamp et al, 2015) , we had evaluated all potential confounders by assessing overall model fit with the variance inflation factor for collinearity and the likelihood ratio test to determine the set of covariates. For consistency with the earlier study, we maintained this set as the 'a priori' covariates in the logistic regression models.
As noted by the reviewer, the issue of alcohol and gastroschisis is complex. In the literature, alcohol, as well as many other exposures, are inconsistently associated with gastroschisis. We re-checked our current dataset and confirmed that smoking and alcohol are highly correlated and smoking has been reported more consistently. We re-ran the overall odds ratios for each infection type, adding alcohol into the logistic regression model, and the estimates were within 1% of those reported in our manuscript. This finding, in addition to our previous work, made us decide to exclude alcohol exposure from our list of a priori confounders.
5.
Other limitations need to be presented, including differential recall of pregnancy-related factors between cases and controls, limitations in the reliability of self-reported smoking, and preconception BMI.
We added the following sentences to the paragraph on limitations in the Discussion section:
Other limitations include the time from EDD to interview which may affect recall of infection, cigarette smoking or preconception weight used to calculate BMI. Recall bias of a GUI is a concern and may have impacted our study's findings. Misdiagnosis of the GUI and asymptomatic infection, are also a concern. An ideal approach would be to combine prenatally collected serum biomarkers with review of the prenatal medical records. 21 However, the potential for reporting bias of cigarette smoking in the NBDPS was assessed using two different methods, which did not find any evidence of differential recall. 62, 63 Another study found maternal smoking was actually more often reported in the NBDPS interview compared to the medical record or birth certificate data. 64 Preconception weight is known to be underreported by 1-2 kg and is most pronounced in the obese group, 65 but would not be expected to differ by case-control status. This misclassification would likely shift effect estimates toward the null, thus underestimating the true risk. To minimize misclassification bias, the NBDPS used trained interviewers, blinded to case-control status, and used a computerized and scripted questionnaire to capture exposure information. Confounding by indication (antibiotic use) was not examined as a recent analysis 66 assessed the risk of birth defects associated with the use of different antibiotics and gastroschisis was not associated with these medications. Finally, residual (unmeasured) confounding may have influenced the study's findings.
6. Can you discuss if underreporting of STIs in NBDPS could have resulted in non-differential misclassification of this exposure, and if so, how could it have influenced your findings? Or that bias can be complex to explore due to asymptomatic infections.
We now discuss these issues in the paragraph on limitations (Discussion section: please refer to question #5 above).
Nondifferential misclassification (reporting of an STI) is a concern but less so than those that are asymptomatic infections (70-90% for all women). Both case and control women would be at risk of having an asymptomatic STI. The result of any nondifferential misclassification would bias the effect estimates toward the null (OR=1). Our findings in this study would then be an underestimate of the association between STI and gastroschisis. Our study provides a clue about STIs and gastroschisis.
7.
Please provide a reason why medication use for GUI was not examined as a part of this analysis?
We added the following sentence to the section on limitations:
Confounding by indication (antibiotic use) was not examined as a recent analysis (Ailes et al, 2016) assessed the risk of birth defects associated with the use of different antibiotics and gastroschisis was not associated with these medications.
Reviewer: 2
The critical period for most major congenital anomalies is during organogenesis, in the first trimester of pregnancy. 1. I would like to see more information on the numbers exposed specifically during this period (not just the B3P3 period) in Table 1 : could we have the % with UTI or STI among cases and controls for P1P3 as well as B3P3.
As noted by the distinguished reviewer, congenital anomalies, including gastroschisis, occur during the period of organogenesis. However, if an exposure (in this study, infection) occurs prior to conception and this infection causes a maternal pro-inflammatory response, the systemic inflammation may last well into the first trimester. It may not be the pathogen itself that causes gastroschisis, but the woman's immunologic response. For this reason, we would prefer to maintain the B3P3 information. This pattern was similar when the timing of the reported GUI was restricted to before (B3B1) or after (P1P3) conception (data not shown).
2.
3. More discussion of the results relating to this period of exposure would also be useful for e.g. in Figure 2 the aORs for both P1P3 STI and UTI are significant among all ages and those ≥25. This is interesting given the relationship between young maternal age and gastroschisis.
We have edited the sentence in the second paragraph of the Discussion section to explain why there is a risk for all age groups:
With increasing age, these columnar cells increasingly convert to squamous epithelial cells that line the cervix, which are less susceptible to these two pathogens, 12 but if this barrier is breached, the pathogen can access cells in the basal layer.
4.
The reviewer asks a very important question that requires testing for both anti-pathogen antibodies and the subsequent maternal inflammatory response. We are currently trying to investigate this hypothesis using prenatally collected serum and PBMCs. To account for the lack of references we rephrased the sentence to say "We postulate".
Limitations
5.
Interview up to 2 years following the EDD should be acknowledged. Women may not have recalled their infection (helping to explain the lower rates of GUI seen than expected) or may have recalled the timing of infection inaccurately.
We have added information on the time to interview to the methods (9.5 months for case women and 8.6 months for control women) and we have added infection recall to the paragraph on limitations in the Discussion section:
Other limitations include the time from EDD to interview which may affect recall of infection, cigarette smoking or preconception weight used to calculate BMI. Recall bias of a GUI is a concern and may have impacted our study's findings. Misdiagnosis of the GUI and asymptomatic infection, are also a concern. An ideal approach would be to combine prenatally collected serum biomarkers with review of the prenatal medical records. 21 6. Similarly, there may be underestimation of STI in particular if women were reluctant to admit they had an STI to the interviewer. There may also have been an element of recall bias with the mother of an infant with gastroschisis more likely to recall an exposure than the mother of a non-malformed infant leading to an overestimation of exposure among malformed infants. I would therefore question the statement that 'risk estimates should represent a lower boundary of the true risk' (page 17).
As mentioned above in response to reviewer 1 (question 5), we now discuss the issue of exposure misclassification in the paragraph on limitations (Discussion section). However, we are more concerned about those women that are asymptomatic and infected (70-90%).
7.
Thank you, we have added this reference to the manuscript.
Reviewer: 3 1. Abstract: Strengths and limitations of this study: The only limitation the authors state is the issue of the potential misclassification of asymptomatic women as unexposed which would impact both control and cases equally.
The abstract is limited to 250 words. However, we have added the following information to the section following the abstract on Strengths and Limitations of this Study.
o Mothers of cases and controls were interviewed by trained interviewers using a computerizedaccess telephone interview between six weeks and 24 months after the estimated date of delivery. Recall bias may impact the findings of this study.
However, the authors should be more forthcoming in regard to more significant limitations both in this section and within the main body of the manuscript. A significant limitation that should be included is the retrospective nature of the data, collected up to 2 years post event. Also, the potential recall bias between the two groups of cases and control, they potentially recall events of early pregnancy quite differently. Women who have a pregnancy affected by a significant fetal anomaly may well examine carefully all their activities and medical conditions that may have potentially contributed to the pregnancy complication as opposed to women with an unaffected pregnancy. The recall up to two years after the birth would potentially be different. This should be stated as a limitation of the study design.
As suggested by this reviewer and reviewer 1, we have added information to the paragraph on limitations in the Discussion section:
Material and methods: Case classification
As suggested, we have added this information to the fourth paragraph in the Methods section:
The median time from EDD to interview was (9.5 +/-6.3 months) for cases and (8.6 +/-6.5 months) for controls.
The one-month difference is likely due to the need for the surveillance system to first to identify a potential case with an eligible birth defect, confirm its eligibility, and have the local geneticist review the case prior to inviting the mother to participate in the study. We chose to present the median time since the time to interview distributions are not normally distributed.
3. Statistical analysis: Analysis and conclusion in regards to associations within subgroups may be driven by sample size, further review is recommended by Journal statistician.
Not applicable to the authors' response.
Conclusion-For clarity to the reader the authors should report n values.
For example page 13 line 9 the authors state the strongest association for STI prior to conception was with women < 20 years, reporting the number of women the association is made from would be more transparent.
The numbers by maternal age are presented in the paragraph on Risk by type of STI pathogen. C. trachomatis was reported more often in women less than 20 years of age (cases 16/25, 64%; controls 22/33, 67%) than among women aged 20-24 years (cases 7/21, 30%; controls 30/77, 39%) and women 25 years and older (cases 2/9, 22%; controls 6/81, 7%).
On page 14 line 21 the authors again only report percentages for known STI organisms which is misleading to the reader "(50% of case mother and 36% of control mothers)", please include number of women.
The numbers (%) were originally included in the last paragraph of the results section. As suggested by the reviewer, we have repeated these numbers in the first paragraph in the Discussion section.
5:
Errors: Page 3 line 44 error: incorrect percentage 84.3% should be 84.8% Line below the percentage is rounded but others are not, can the authors be consistent.
We thank the reviewer for catching this error. We changed these to 84% and 85%, respectively. The numbers are correct in the figure and text. There were cases and controls that reported two pathogens each. We clarified this in the manuscript as indicated below:
Among those women reporting an STI, 89% (50/56) of the case women and 85% (162/191) of the control women were able to report a specific pathogen (1 case and 9 controls reported two pathogens each):
7. Table 1 needs clarification added that percentages are of total not of number of responders.
We revised the percentages for cases and controls in the "All" category and excluded any with missing data from these percentages.
Reviewer: 4
This paper reports on the results of a case-control study to examine whether genitourinary infections are a risk factor for gastroschisis in a population-based sample of pregnant women in the US. The paper extends on a previous analysis of the same topic (previously published in the BMJ in 2008), with additional subjects and more detailed exposure data to those in the original study. It is a wellstructured paper on an important topic which merits publication, although I have identified some issues that require further clarification.
1.
Methods: "Patient and public involvement" on page 6: This section explains how the study subjects were defined and recruited, rather than the role of patients or lay members of the study team in planning and designing the study (as the term PPI would be understood in the UK).
We have included the following information in the methods section: Patient and Public Involvement (PPI): Two federal mandates were responsible for the creation of the Centers for Birth Defects Research at CDC 24 : the Congressional mandate in 1996 and the Birth Defects Prevention Act in 1998. After these mandates, the NBDPS was designed and conducted by participating centers around the country. Mothers of infants with and without a birth defect were not involved in the study design or questionnaire development, however participants were asked: "Is there anything, including some of the factors we've talked about that you think might cause birth defects?" and the responses were considered when making changes to the questionnaire. The NBDPS collaborators have shared results of some analyses via a NBDPS newsletter with participants, available on the NBDPS website (http://nbdps.org).
2.
As suggested, we have added this information to the Methods section:
The median time from EDD to interview was 9.5 (+/-6.3) months for case women and 8.6 (+/-6.5) months for control women.
We have also added information to the paragraph on limitations in the Discussion section (please refer to review 1, question #5 above).
3. Exclusion on page 7: Were mothers with pregestational diabetes excluded because gestational diabetes was to be examined as a possible risk factor in the analysis?
Because pregestational diabetes is a known human teratogen, we chose to exclude any case or control woman reporting this condition.
4.
We moved this statement to the beginning of the paragraph and added the numbers to minimize confusion:
Overall participation rates were 65% (1506 interviewed/2332 eligible) for case and 64% (11.329 interviewed/18,614 eligible) for control mothers.
5.
Exposure assessment on page 7: It is stated that women who said that they had PID were considered to have an STI. However, it is not clear from the description of the questions above this statement that the question on UTIs and PID were separate questions (both questions are included under question a)). Therefore, it is not clear how it's possible to separate women who had UTIs from women who had PID. If these were two separate questions, this should be clarified. Otherwise, it should be clear how the distinction between UTI and PID was made from these questions.
We have hopefully made this clearer with the revised version. There were three separate questions:
Three questions captured information on UTI and/or STI: 'Did you have any of the following illnesses: a) 'a kidney, bladder, or urinary tract infection'?; b) 'Pelvic Inflammatory Disease or PID?'; and c) 'Did you have any other diseases or illnesses that we have not already talked about such as… sexually transmitted diseases?'.
6. Variables in the model on page 8: A set of covariates for adjustment that were specified a priori is given. This list includes some measures of socio-economic status (such as age and race) but not others (such as education, occupation and/or a measure of wealth). A justification for this is not given (see comment below on the possibility of residual confounding)
We added the following to the sentence: Based on our previous work (Feldkamp et al, 2015) , odds ratios … 7. No sample size or power calculations are given. This is important in the interpretation of the results, because all of the associations shown in supplementary table 1 are significant in women aged >=25 but this is also the largest group. It is not clear that the study is large enough to show a difference when the data are stratified by infection type, timing and age of the mother.
Prior to the analytical phase of this project, power calculations were done on the entire case-control group. The information in supplemental table 1 shows the 95% confidence intervals that provide a range of values around the estimates (odds ratios). Power estimates would not benefit the reader when the findings are statistically significant with 95% confidence interval. The estimates that are not statistically significant may indeed have very low power due to the smaller sample size but assessing power on those estimates that are statistically significant does not provide any additional information.
Power estimates based on a minimal detectable odds ratio of 1.5 for prevalence of a GU infection among controls. Figure 2 is a helpful summary of the main results (especially as it's clear which confidence intervals overlap), although this doesn't show all of the data in supplementary table 1. I'm not sure of the policy of this journal, but some journals require that odds ratios with CIs are plotted on a logarithmic scale. Given that several of the confidence intervals on this figure are wide, this would probably provide a clearer visualisation of the results in this case.
GU Infection Prevalence Among Controls
9.
Below we show both options for the ORs (logarithmic ORs on the lower half) for Figure 2 . The log scale seems to be somewhat misleading to the eye. In addition, we are not seeing a preventive effect (ORs below 1) which is where the log scale might be more useful. Rothman et al (Am J Epidemiol 2011:174(3):376-377) argue that graphs on the arithmetic scale will be less visually misleading than the log scale. However, if the Editor prefers, we would change these figures to show the ORs in log scale.
10. I also wondered whether table 2 would be better shown using a similar figure (with estimates and 95% CIs), so that the reader can see clearly which CIs overlap and which do not? To make way for this, Figure 1 could be taken out as this can easily be summarised in words.
While a figure is a very reasonable option to visualize the results, we would prefer to keep table 2 as presented, not only because the upper bounds of confidence intervals are challenging to represent on the x-axis, but also because Table 2 provides, in our view, more precise information (counts and interval boundaries) that could be useful to future researchers.
11
. Discussion: The authors discuss the limitations of using maternal recall of infections in general. However, there is potential for differential recall bias in this study, as mothers of babies with gastroschisis may recall and report their exposure to infections in a different way to mothers of babies without gastroschisis. This becomes more likely as the time after the delivery increases (which is why it's important for data on this to be presented). Is it also possible that mothers of babies with gastroschisis may be more likely to notice symptoms or to be investigated for STIs, therefore also introducing a differential information bias (as they may be more likely than control mothers to know their infection status)? This should be explicitly mentioned in the discussion with a statement on how this might affect the interpretation of the ORs.
We have revised the paragraph on limitations. However, we respectfully disagree with the reviewer that mothers of babies with gastroschisis may be more likely to notice symptoms or be investigated for their STI. Symptoms and the clinical evaluation would have occurred prior to the prenatal diagnosis of gastroschisis (diagnostic ultrasound performed after 18 weeks gestation).
12.
There is also potential for residual confounding, especially if not all variables relating to the socioeconomic status of the mothers were included in the multivariable models (and cases and controls are shown to differ in terms of education). Again, this should be explicitly mentioned in the discussion with a statement on how this might affect the interpretation of the ORs.
As suggested by the reviewer, we have added the following sentence to the paragraph on limitations in the Discussion section:
Finally, residual (unmeasured) confounding may have influenced the study's findings.
13.
Minor comments
14. Page 3 -the sentence in the results section of the abstract which starts "The risk was also increased with UTI before…" is long and difficult to understand.
We have revised the abstract to read:
The risk was increased with a UTI before (aOR=2.5; 1.4, 4.5) or after (aOR=1.7; 1.1, 2.6) conception only among women >25 years of age. The risk was highest among women <20 years of age with an STI before conception (aOR=3.6; 1.5, 8.4) and in women >25 years of age, the risk was similar for before (aOR=2.9; 1.0, 8.5) and after (aOR=2.8; 1.3, 6.1) conception.
15.
We have made this suggested change.
16. Page 17 -"these risk estimates…" should read "these estimates"
As suggested by the reviewer we have deleted the work "risk" in this sentence.
VERSION 2 -REVIEW
REVIEWER
Vijaya Kancherla Emory University Rollins School of Public Health
REVIEW RETURNED
19-Dec-2018
GENERAL COMMENTS
The authors have addressed reviewer comments.
